Isabella List Updates

Psilocybin Teen Risks: Hidden Dangers of Magic Mushrooms

A dangerous trend is sweeping through teenage communities as psilocybin teen risks escalate rapidly. Young people are treating magic mushrooms like harmless experiments, but the reality is far more sinister. These substances are triggering permanent mental illness in developing brains. The research doesn’t just suggest concern; it screams alarm about adolescent psychedelic use destroying young […]

Psilocybin Teen Risks: Hidden Dangers of Magic Mushrooms Read More »

Update on the Behavioral and Neurobiological Effects of Cannabis Use in Adolescents: A Translational Perspective

  The convergence of early initiation, increasing product potency, and widespread availability has reshaped the contemporary cannabis landscape, heightening concerns about its impact on adolescent mental health. Translational research combining longitudinal human neuroimaging and animal models provides compelling evidence that cannabis use—particularly with high-tetrahydrocannabinol (THC) products and frequent use—can disrupt adolescent brain development and behavior.

Update on the Behavioral and Neurobiological Effects of Cannabis Use in Adolescents: A Translational Perspective Read More »

Australia Seizes 10 Million Vapes: World-Leading Crackdown Shows Dramatic Results in Youth Prevention

Breaking News from Australia shows unprecedented success in tackling youth vaping epidemic as government reports peak vaping rates behind them Australia has achieved a remarkable milestone in youth substance abuse prevention, with border authorities seizing over 10 million vapes since implementing world-leading import controls in January 2024. The comprehensive crackdown has successfully turned the corner

Australia Seizes 10 Million Vapes: World-Leading Crackdown Shows Dramatic Results in Youth Prevention Read More »

Non-Pharmaceutical Grade CBD passed off as ‘Medicinal Cannabis’ & Liver Damage

Cannabidiol (CBD) and Liver Enzyme Level Elevations in Healthy Adults: A Randomized Clinical Trial Conclusions: In this randomized double-blind clinical trial of healthy adults administered CBD, 5mg/kg/d for 28 days, 8 (5.6%) experienced liver enzyme level elevations and 7 (4.9%) met protocol defined criteria for potential DILI. This research has important implications for consumer safety. The

Non-Pharmaceutical Grade CBD passed off as ‘Medicinal Cannabis’ & Liver Damage Read More »

Social Media Teen Substance Use Crisis: How Online Platforms Are Driving Youth Vaping and Cannabis Epidemic

  New research exposes alarming connections between social media teen substance use patterns and dangerous dual addiction risks BREAKING: A comprehensive new study published in JAMA Network Open has revealed disturbing evidence about social media teen substance use. The research shows that e-cigarette and cannabis content exposure is actively fuelling substance use among young people. Platforms

Social Media Teen Substance Use Crisis: How Online Platforms Are Driving Youth Vaping and Cannabis Epidemic Read More »

Scroll to Top